Omeros Corp - Company Profile
Powered by 
All the data and insights you need on Omeros Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Omeros Corp Strategy Report
- Understand Omeros Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Omeros Corp (Omeros) discovers, develops and commercializes small-molecule and protein therapeutics and orphan indications for the treatment of inflammation, coagulopathies and disorders of the central nervous system (CNS). The company reports its operations under single segment.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Omeros conducts research and development (R&D) to advance its product candidates to commercialization. The company also focuses on complement mediated disease, central nervous system disorders and immuno-oncology. The company works in collaboration with various clinical sites to conduct its trials. In FY2022, it incurred R&D expense of US$112.7 million. As of December 2022, the company has employed 130 personnel for R&D activities. As of February 2023, the company held worldwide exclusive licenses to a total of 77 issued patents and 62 pending patent applications in the US; and 1,285 issued patents and 595 pending patent applications in foreign markets.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer